`
Monday, 26 June 2017

Drug Discovery News

  • RaQualia, Interprotein to research on pain drug

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 04 Feb, 2013

    Singapore: RaQualia Pharma and Interprotein entered into a collaborative research agreement. The partnership will focus on drug discovery research for a specific protein-protein interactio...Read more

  • Novartis gets EU nod for combination therapy for skin cancer

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 27 Jul, 2015

    Singapore: European Medicines Agency (EMA) has given a positive indication to Novartis' combination therapy of Tafinlar (dabrafenib) and Mekinist (trametinib) for the treatment of adult pat...Read more

  • Chemistry Nobel winner, Dr Irwin Rose, dies at 88

    Drug Discovery |  Influencers | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2015

    Singapore: Dr Irwin Rose, an American biologist, who shared Nobel Prize in Chemistry in 2004 for the discovery of cell behaviour of destroying unwanted protien, died at the age of 88. Dr R...Read more

  • Novartis' Enbrel positive in psoriasis study

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 09 Jul, 2013

    Singapore: Novartis' phase III psoriasis study of secukinumab (AIN457) has showed positive outcome in clearing skin to Enbrel (etanercept), an anti-tumor necrosis factor (anti-TNF) therapy....Read more

  • China firms Shuwen, Hengrui to build companion diagnostics

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 31 Jul, 2015

    Singapore: China based diagnostic company, Shuwen Biotech, and pharmaceutical firm, Jiangsu Hengrui Medicine have partnered to build companion diagnostics for cancer. Shuwen Biotech will d...Read more

  • Bayer conducts Xarelto trials on cancer patients

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 29 May, 2015

    Singapore: Bayer HealthCare and its development partner Janssen Pharmaceuticals have initiated the CALLISTO Clinical Research Program to explore the potential benefits of the oral Factor Xa...Read more

  • Singapore's ASLAN pharma inks MoU with NCCS

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 20 Jul, 2015

    Singapore: ASLAN Pharmaceuticals has inked a memorandum of understanding with Singapore's National Cancer Center (NCCS) to develop newer therapies and intensify research of novel agents for...Read more

  • Pancreatic cancer drug pipeline rich but slow'

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 18 Jun, 2015

    Singapore: While the treatment pipeline for pancreatic cancer shows a high level of innovation, with 52 percent of products categorized as first-in-class, most development is in the early s...Read more

  • FDA approves new drug for chemo induced vomiting

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 03 Sep, 2015

    Singapore: US Food and Drug Administration has approved Varubi (rolapitant), marketed by US based, to prevent delayed phase chemotherapy-induced nausea and vomiting (emesis). Varubi is appr...Read more

  • BMS appoints Dr Thomas Lynch to its board

    Drug Discovery |  Influencers | By BioSpectrum Bureau | 0 Comment | 11 Dec, 2013

    Singapore: Bristol-Myers Squibb has elected Dr Thomas J Lynch to the board, effective January 1, 2014. Dr Lynch will serve as a member of the science and technology committee of the board o...Read more

  • Novocure launches Optune in 23 brain cancer centers in Japan

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 01 Jun, 2015

    Physicians at 23 brain cancer centers in Japan are now certified to provide Optune to recurrent glioblastoma patients on prescription order. US-based Novocure, a commercial stage oncology c...Read more

  • Crystal Pharmatech, Partner Sciences join hands

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 27 Feb, 2013

    Singapore: Crystal Pharmatech, a technology-driven solid-state research contract research organization (CRO) based China, has partnered with Particle Sciences, a leading contract drug devel...Read more

  • Eisai, Quintiles cancer drug program shows +ve results

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 13 Jun, 2013

    Singapore: Eisai has revealed therapeutic effects of lenvatinib (generic name- VEGF receptor tyrosine kinase inhibitor and multi-kinase inhibitor discovered in-house) on melanoma. The firm...Read more

  • Strides Shasun receives USFDA approval for Dutasteride Softgel Capsule

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 23 Nov, 2015

    The product is ready for Day 1 launch, said Strides in a press release. Dutasteride is used to treat benign prostatic hyperplasia (BPH; enlargement of the prostate gland). The product has...Read more

  • Eisai publishes phase III results of anti-seizure drug

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 26 Jul, 2012

    Singapore: Eisai published the results of its 'adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304' online in the July 25, 2012, edition of Neurology...Read more

  • Gene therapy pipeline in oncology is rich but at early stage'

    Drug Discovery |  Analysis | By BioSpectrum Bureau | 0 Comment | 29 Sep, 2015

    Singapore: Despite few products having so far reached the market and captured strong revenues, the gene therapy pipeline remains large, with 906 products in active development across all st...Read more

  • PharmaEngine files NDA for metastatic cancer drug

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 02 Jun, 2015

    Singapore: Taiwan's PharmaEngine has filed a New Drug Application (NDA) to the Taiwan Food and Drug Administration (TFDA) for MM-398 (irinotecan liposome injection, also known as nal-IRI) i...Read more

  • AOP Orphan launches drug for Lipodystrophy in HIV patients

    Drug Discovery |  News | By BioSpectrum Bureau | 0 Comment | 13 Aug, 2015

    Singapore: AOP Orphan, a pharmaceutical company in the field of rare diseases, has launched world's first drug approved by the FDA that can be used effectively against lipodystrophy (excess...Read more

Survey Box

Will Asia- Pacific healthcare IT market hit the double digit growth in the next five years?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls